12,000,000 Shares Inverness Medical Innovations, Inc. Common Stock, par value $.001 per share UNDERWRITING AGREEMENTUnderwriting Agreement • November 16th, 2007 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • New York
Introductory. Inverness Medical Innovations, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 11,834,302 shares of its common stock, par value $.001 per share (the “Shares”); and the stockholders of the Company named in Schedule B (collectively, the "Selling Stockholders”) severally propose to sell to the Underwriters an aggregate of 165,698 Shares, with each Selling Stockholder selling up to the amount set forth opposite such Selling Stockholder’s name in Schedule B. The 11,834,302 Shares to be sold by the Company and the 165,698 Shares to be sold by the Selling Stockholders are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 1,800,000 Shares. The additional 1,800,000 Shares to be sold by the Company are called the “Optional Shares.” The Firm Shares and, if and to the extent such option is exercised, t
